| Cat. No. |
Product Name |
Information |
| PC-62041 |
U-46619
TP agonist
|
U-46619 is a potent and stable thromboxane A2 (TP) receptor agonist with EC50 of 35 nM. |
| PC-62029 |
TG4-155
EP2 antagonist
|
TG4-155 is a potent and selective prostaglandin EP2 receptor antagonist with Kb of 2.4 nM. |
| PC-61577 |
AM432 sodium
CRTH2 inhibitor
|
AM432 is potent, selective, orally active prostaglandin D2 receptor (DP2/CRTH2) antagonist with binding IC50 of 6 nM for hDP2. |
| PC-61566 |
ARRY-502
CRTH2 inhibitor
|
ARRY-502 is an orally bioavailable, potent and selective antagonist of the prostaglandin D2 receptor (CRTh2) for treatment of mild to moderate Th2-driven asthma. |
| PC-61565 |
MK-7246
CRTH2/GPR44 inhibitor
|
MK-7246 is a potent, selectie, orally available prostaglandin D2 receptor (CRTH2, GPR44) antagonist with Ki of 2.5 nM (hCRTH2). |
| PC-61564 |
TASP0376377
CRTH2 inhibitor
|
TASP0376377 is a potent, selective prostaglandin D2 receptor (CRTH2) antagonist with binding IC50 of 19 nM. |
| PC-61563 |
BI 671800
CRTH2 inhibitor
|
BI 671800 is a potent, oral prostaglandin D2 receptor (DP2/CRTH2) antagonist with IC50 of 4.5 nM and 3.7 nM for PGD2 binding to CRTH2 in hCRTH2 and mCRTH2 transfected cells, respectively. |
| PC-61555 |
ER-819762
EP4 antagonist
|
ER-819762 is a novel potent, selective, orally active EP4 receptor antagonist with IC50 of 59 nM in cAMP-dependent reporter assay. |
| PC-61499 |
AAT-008
EP4 antagonist
|
AAT-008 is a potent, and selective prostaglandin EP4 receptor antagonist with binding IC50 of 2.4 nM. |
| PC-60722 |
BMY 45778
Prostacyclin agonist
|
BMY 45778 is a potent, non-prostanoid prostacyclin partial agonist that potently inhibits human (IC50=35 nM), rabbit (IC50=136 nM) and rat (IC50=1.3 uM) platelet aggregation. |
| PC-60721 |
ONO-1301
Prostacyclin agonist
|
ONO-1301 is a stable, orally active, non-prostanoid prostacyclin I2 (PGI2) mimetic and prostacyclin agonist with inhibitory activity against thromboxane A2 synthase. |
| PC-60673 |
AM211
DP2 antagonist
|
AM211 (AM-211) is a potent, selective and orally bioavailable prostaglandin D2 receptor type 2 (DP2) antagonist with IC50 of 4.9 nM for human DP2. |
